5 Small-Cap Stocks to Buy According to Ken Fisher
In this article, we discuss 5 small-cap stocks to buy according to Ken Fisher.
Posts Tagged ‘NASDAQ:BCRX’
Analysts Are Downgrading These 10 Pharmaceutical Stocks
In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.
10 Biotech Stocks to Buy Today According to Ken Fisher
In this piece, we will take a look at the ten biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
Do Hedge Funds Love BioCryst Pharmaceuticals, Inc. (BCRX)?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
15 Good Stocks to Buy Right Now
Investors are practicing extreme caution amid uncertainty caused by the resurgence of COVID-19 all over the world.
5 Biotech Stocks Popular On Reddit
In this article, we discuss the 5 biotech stocks popular on Reddit.
Is BioCryst Pharmaceuticals, Inc. (BCRX) Going to Burn These Hedge Funds?
A whopping number of 13F filings filed with U.S.
Billionaire Steve Cohen’s Top 10 Small-Cap Stock Picks
In this article we presented billionaire Steve Cohen's top 10 small-cap stock picks.
Billionaire Steve Cohen’s Top 5 Small-Cap Stock Picks
In this article we discuss the billionaire Steve Cohen's top 5 small-cap stock picks.
Is BCRX Stock A Buy or Sell?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
10 Best Small-Cap Biotech Stocks Under $10 in 2021
We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology.
Is BCRX A Good Stock To Buy Now According To Hedge Funds?
In this article we will take a look at whether hedge funds think BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a good investment right now.
Hedge Funds Keep Buying BioCryst Pharmaceuticals, Inc. (BCRX)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On BioCryst Pharmaceuticals, Inc. (BCRX) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been This Bullish On BioCryst Pharmaceuticals, Inc. (BCRX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Here is What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
BioCryst Pharmaceuticals, Inc. (BCRX) Are Selling These Hedge Funds
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
Is BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Here’s What Hedge Funds Think About BioCryst Pharmaceuticals, Inc. (BCRX)
Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
BioCryst Pharmaceuticals, Inc. (BCRX) Hedge Funds Are Snapping Up
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
13D Filing: RA Capital Management and Biocryst Pharmaceuticals Inc (BCRX)
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)
You can access the original SEC filing by clicking here.
33 Fresh Stories From The World Of Finance Today
"World stock markets scaled fresh highs on Thursday, with key U.S. indexes lifted by rosy retailer results, while the U.S.
13G Filing: James E. Flynn and Biocryst Pharmaceuticals Inc (BCRX)
You can access the original SEC filing by clicking here.
BioCryst Pharmaceuticals, Inc. (BCRX): A Discount Entry?
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has caught our attention in the biotech space as being a company that has had a bit of a strange start to the week.
What Smart Money Thinks about BioCryst Pharmaceuticals, Inc. (BCRX)?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares
Julian Baker and Felix Baker's Baker Bros.
Most Popular Healthcare Stocks Under $5
Most securities that cost less than a dinner at a fast-food restaurant are considered to be too risky, with most intra-day traders or other investors usually avoiding these low...
Biotech-Focused VHCP Management’s Bullish Moves and New Picks
Biotech stocks pop and drop on the smallest whims and whispers, which makes the biotechnology sector one of the most rewarding and volatile sectors out there.
Venrock Healthcare Capital Partners Discloses 7.1% Stake in Biocryst Pharmaceuticals Inc (BCRX)
Anders Hove and Bong Koh's VHCP Management owns a new position in BioCryst Pharmaceuticals, Inc.
D. E. Shaw & Co Raises Exposure to Biocryst Pharmaceuticals Inc (BCRX)
D. E. Shaw & Co, founded by billionaire David E. Shaw, has reported its position in BioCryst Pharmaceuticals, Inc.
Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves
There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking the moves of elite hedge...
These 4 Stocks Were Just Bought by Baker Bros. Advisors, Clint Carlson, More
The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990.
Elite Hedge Funds Making Moves in These Three Stocks
Most investors monitor hedge funds’ 13F filings in order to identify high-potential stocks, and our research has provided evidence that these public filings bury inside numerous...
Gap Inc, ANI Pharmaceuticals, Ruby Tuesday: Why Are These Stocks Getting Crushed Today?
It's been a disappointing day for investors of Gap Inc (NYSE:GPS), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Ruby Tuesday, Inc.
RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains
According to a recent filing with the Securities and Exchange Commission, Peter Kolchinsky's RA Capital has initiated a position in Alcobra Ltd (NASDAQ:ADHD), acquiring some 1...
Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Earnings Watch News: Alcoa Inc (AA), JPMorgan Chase & Co. (JPM), Wells Fargo & Co (WFC)
Alcoa Inc (NYSE:AA) will provide the informal kickoff to first-quarter earnings season Monday afternoon as the first Dow Jones industrial average component to report figures ...
Hedge Funds Are Selling BioCryst Pharmaceuticals, Inc. (BCRX)
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders have witnessed a decrease in hedge fund interest lately.
